A few days ago, The Marker released an update on the status of Israeli venture capital. It turns out that 28 funds have been hurt from the current economic downturn. More than 7 funds have executed lay-offs in more than five portfolio companies each. One of the most impacted funds was Pitango, Israel’s largest VC fund, which closed one portfolio company (Negevtech), seven portcos laid off employees and three companies were sold for a loss. Sequoia is not in a much different condition. The fund has reportedly laid off more than 500 people in its global portfolio, and five Israeli start ups have been impacted. In the post “The Sequoia Layoff Scorecard” Om Malik reports on the scope of the lay-offs made by Sequoia (courtesy of Brendan Gahan and Susie Lin): Among the Israeli companies that were hit by the recent wave were Personata, ScaleMP, Amobee, Pontis and Discretix. The deepest cut was made by online shoe retailer Zappos, who eliminated 128 posititons. Sequoia Israel has been relatively successful so far, with more than eight successful exits.
Chief Innovation Officer at Antidote
Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Ezewas a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google's first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He's an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.